ID   EST1_PIG                Reviewed;         566 AA.
AC   Q29550; O97582; P82128;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   07-APR-2021, entry version 119.
DE   RecName: Full=Liver carboxylesterase;
DE            EC=3.1.1.1;
DE   AltName: Full=Proline-beta-naphthylamidase;
DE   AltName: Full=Retinyl ester hydrolase;
DE            Short=REH;
DE   Flags: Precursor;
OS   Sus scrofa (Pig).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Laurasiatheria; Artiodactyla; Suina; Suidae; Sus.
OX   NCBI_TaxID=9823;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Liver;
RX   PubMed=1959668; DOI=10.1016/0014-5793(91)81147-z;
RA   Matsushima M., Inoue H., Ichinose M., Tsukada S., Miki K., Kurokawa K.,
RA   Takahashi T., Takahashi K.;
RT   "The nucleotide and deduced amino acid sequences of porcine liver proline-
RT   beta-naphthylamidase. Evidence for the identity with carboxylesterase.";
RL   FEBS Lett. 293:37-41(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 19-44, FUNCTION, CATALYTIC
RP   ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Intestinal mucosa;
RX   PubMed=9799112; DOI=10.1046/j.1432-1327.1998.2570142.x;
RA   David L., Guo X.-J., Villard C., Moulin A., Puigserver A.;
RT   "Purification and molecular cloning of porcine intestinal glycerol-ester
RT   hydrolase -- evidence for its identity with carboxylesterase.";
RL   Eur. J. Biochem. 257:142-148(1998).
RN   [3]
RP   PROTEIN SEQUENCE OF 19-29; 66-79; 84-90; 314-326; 384-401 AND 438-452,
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVITY REGULATION, AND BIOPHYSICOCHEMICAL
RP   PROPERTIES.
RC   TISSUE=Liver;
RX   PubMed=9490062; DOI=10.1046/j.1432-1327.1998.2510863.x;
RA   Schindler R., Mentlein R., Feldheim W.;
RT   "Purification and characterization of retinyl ester hydrolase as a member
RT   of the non-specific carboxylesterase supergene family.";
RL   Eur. J. Biochem. 251:863-873(1998).
RN   [4]
RP   FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=16223870; DOI=10.1124/jpet.105.092726;
RA   Landowski C.P., Lorenzi P.L., Song X., Amidon G.L.;
RT   "Nucleoside ester prodrug substrate specificity of liver
RT   carboxylesterase.";
RL   J. Pharmacol. Exp. Ther. 316:572-580(2006).
CC   -!- FUNCTION: Involved in the detoxification of xenobiotics and in the
CC       activation of ester and amide prodrugs. Active towards
CC       triacylglycerides containing short-chain fatty acids from C2 to C6, and
CC       1(3)-monoacylglycerols containing fatty acids from C2 to C12. Inactive
CC       on long-chain triacylglycerols and diacylglycerol. Hydrolyzes aromatic
CC       and alkyl esters and vitamin A acetate. The hydrolysis rate depends
CC       upon the amino acid promoiety and the esterification site of the
CC       prodrug. Aromatic promoieties are favored, highest rates are observed
CC       with phenylalanyl progdrugs, hydrolysis of valyl and isoleucyl prodrugs
CC       is less efficient. With floxuridine prodrugs, activity is higher on 5'
CC       monoesters than on 3' monoesters. With gemcitabine prodrugs, activity
CC       is higher on 3' monoesters than on 5' monoesters.
CC       {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC       ECO:0000269|PubMed:9799112}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a carboxylic ester + H2O = a carboxylate + an alcohol + H(+);
CC         Xref=Rhea:RHEA:21164, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29067, ChEBI:CHEBI:30879, ChEBI:CHEBI:33308; EC=3.1.1.1;
CC         Evidence={ECO:0000255|PROSITE-ProRule:PRU10039,
CC         ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC   -!- ACTIVITY REGULATION: Activated by CHAPS at concentrations of up to 130
CC       mM, higher concentrations reduce activity. In the presence of CHAPS,
CC       activity is stimulated by non-ionic detergents. Inhibited by the
CC       esterase inhibitors diisopropylfluorophosphate and phenylmethylsulfonyl
CC       fluoride. {ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=27.5 uM for retinyl palmitate {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.46 mM for 5'-L-phenylalanyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.44 mM for 5'-D-phenylalanyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=1.40 mM for 3'-D-phenylalanyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.74 mM for 3'-L-phenylalanyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=1.87 mM for 5'-L-prolyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.97 mM for 5'-L-leucyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=4.85 mM for 3'-L-prolyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=1.46 mM for 3'-L-leucyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=3.08 mM for 3'-L-lysyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=6.25 mM for 5'-L-lysyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=1.11 mM for 3'-L-isoleucyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=3.00 mM for 5'-L-aspartyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.93 mM for 3'-L-aspartyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=4.12 mM for 5'-D-valyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=2.87 mM for 3'-L-valyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=3.58 mM for 5'-L-valyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=2.94 mM for 5'-L-isoleucyl-floxuridine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=11.23 mM for 3'-D-valyl-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.51 mM for 3'-L-phenylalanyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.97 mM for 3'-D-phenylalanyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.17 mM for 5'-L-phenylalanyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.22 mM for 5'-D-phenylalanyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=0.90 mM for 3'-L-valyl-gemcitabine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.94 mM for 3'-L-isoleucyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=1.43 mM for 3'-D-valyl-gemcitabine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.85 mM for 5'-L-isoleucyl-gemcitabine
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         KM=1.16 mM for 5'-D-valyl-gemcitabine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.96 mM for 5'-L-valyl-gemcitabine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.91 mM for 5'-L-phenylalanyl-BDCRB {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.90 mM for 5'-D-phenylalanyl-BDCRB {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.14 mM for pNPB {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.52 mM for pNPA {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=1.18 mM for PHEE {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.08 mM for PHBE {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.40 mM for AcPHEE {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=0.63 mM for 5' cinn-floxuridine {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=4.21 mM for CPT-11 {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         KM=8.81 mM for VACV {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC         Vmax=530 nmol/h/mg enzyme with retinyl palmitate as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.82 nmol/min/ug enzyme with 5'-L-phenylalanyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.63 nmol/min/ug enzyme with 5'-D-phenylalanyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=4.05 nmol/min/ug enzyme with 3'-D-phenylalanyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.55 nmol/min/ug enzyme with 3'-L-phenylalanyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.97 nmol/min/ug enzyme with 5'-L-prolyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.92 nmol/min/ug enzyme with 5'-L-leucyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=4.53 nmol/min/ug enzyme with 3'-L-prolyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.70 nmol/min/ug enzyme with 3'-L-leucyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.59 nmol/min/ug enzyme with 3'-L-lysyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.11 nmol/min/ug enzyme with 5'-L-lysyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.16 nmol/min/ug enzyme with 3'-L-isoleucyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.33 nmol/min/ug enzyme with 5'-L-aspartyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.10 nmol/min/ug enzyme with 3'-L-aspartyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.30 nmol/min/ug enzyme with 5'-D-valyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.19 nmol/min/ug enzyme with 3'-L-valyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.21 nmol/min/ug enzyme with 5'-L-valyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.15 nmol/min/ug enzyme with 5'-L-isoleucyl-floxuridine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.27 nmol/min/ug enzyme with 3'-D-valyl-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=283.52 nmol/min/ug enzyme with 3'-L-phenylalanyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=406.92 nmol/min/ug enzyme with 3'-D-phenylalanyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=3.25 nmol/min/ug enzyme with 5'-L-phenylalanyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=3.19 nmol/min/ug enzyme with 5'-D-phenylalanyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.35 nmol/min/ug enzyme with 3'-L-valyl-gemcitabine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.24 nmol/min/ug enzyme with 3'-L-isoleucyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.32 nmol/min/ug enzyme with 3'-D-valyl-gemcitabine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.09 nmol/min/ug enzyme with 5'-L-isoleucyl-gemcitabine as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.13 nmol/min/ug enzyme with 5'-D-valyl-gemcitabine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.12 nmol/min/ug enzyme with 5'-L-valyl-gemcitabine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=2.33 nmol/min/ug enzyme with 5'-L-phenylalanyl-BDCRB as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.60 nmol/min/ug enzyme with 5'-D-phenylalanyl-BDCRB as
CC         substrate {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=82.25 nmol/min/ug enzyme with pNPB as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=60.45 nmol/min/ug enzyme with pNPA as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=11859.78 nmol/min/ug enzyme with PHEE as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=7.24 nmol/min/ug enzyme with PHBE as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=1.29 nmol/min/ug enzyme with AcPHEE as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=4.00 nmol/min/ug enzyme with 5' cinn-floxuridine as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC         Vmax=0.03 nmol/min/ug enzyme with CPT-11 as substrate
CC         {ECO:0000269|PubMed:16223870, ECO:0000269|PubMed:9490062,
CC         ECO:0000269|PubMed:9799112};
CC       pH dependence:
CC         Optimum pH is 8.0 with tributylglycerol as substrate, and 8.2 with
CC         retinyl palmitate as substrate. Active from pH 4.5-9.5 with retinyl
CC         palmitate as substrate. {ECO:0000269|PubMed:16223870,
CC         ECO:0000269|PubMed:9490062, ECO:0000269|PubMed:9799112};
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum lumen.
CC   -!- SIMILARITY: Belongs to the type-B carboxylesterase/lipase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63323; CAA44929.1; -; mRNA.
DR   EMBL; AF064741; AAC70013.1; -; mRNA.
DR   PIR; S19307; S19307.
DR   RefSeq; NP_001302695.1; NM_001315766.1.
DR   RefSeq; XP_013850047.1; XM_013994593.1.
DR   PDB; 5FV4; X-ray; 2.40 A; A/B/C/D/E/F=19-562.
DR   PDBsum; 5FV4; -.
DR   SMR; Q29550; -.
DR   STRING; 9823.ENSSSCP00000003045; -.
DR   BindingDB; Q29550; -.
DR   ChEMBL; CHEMBL3383; -.
DR   DrugCentral; Q29550; -.
DR   ESTHER; pig-EST1; Carb_B_Chordata.
DR   MEROPS; S09.981; -.
DR   PaxDb; Q29550; -.
DR   PeptideAtlas; Q29550; -.
DR   PRIDE; Q29550; -.
DR   GeneID; 100736962; -.
DR   KEGG; ssc:100736962; -.
DR   eggNOG; KOG1516; Eukaryota.
DR   OrthoDB; 754103at2759; -.
DR   SABIO-RK; Q29550; -.
DR   PRO; PR:Q29550; -.
DR   Proteomes; UP000008227; Unplaced.
DR   Proteomes; UP000314985; Unplaced.
DR   GO; GO:0005788; C:endoplasmic reticulum lumen; IEA:UniProtKB-SubCell.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0052689; F:carboxylic ester hydrolase activity; IBA:GO_Central.
DR   GO; GO:0080030; F:methyl indole-3-acetate esterase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004771; F:sterol esterase activity; IBA:GO_Central.
DR   GO; GO:0004806; F:triglyceride lipase activity; IBA:GO_Central.
DR   GO; GO:0016042; P:lipid catabolic process; IBA:GO_Central.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR002018; CarbesteraseB.
DR   InterPro; IPR019826; Carboxylesterase_B_AS.
DR   InterPro; IPR019819; Carboxylesterase_B_CS.
DR   Pfam; PF00135; COesterase; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
DR   PROSITE; PS00122; CARBOXYLESTERASE_B_1; 1.
DR   PROSITE; PS00941; CARBOXYLESTERASE_B_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Disulfide bond;
KW   Endoplasmic reticulum; Glycoprotein; Hydrolase; Phosphoprotein;
KW   Reference proteome; Serine esterase; Signal.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000250"
FT   CHAIN           19..566
FT                   /note="Liver carboxylesterase"
FT                   /id="PRO_0000008577"
FT   MOTIF           563..566
FT                   /note="Prevents secretion from ER"
FT                   /evidence="ECO:0000255"
FT   ACT_SITE        222
FT                   /note="Acyl-ester intermediate"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU10039"
FT   ACT_SITE        354
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        467
FT                   /note="Charge relay system"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P23141"
FT   CARBOHYD        80
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        88..117
FT                   /evidence="ECO:0000250"
FT   DISULFID        274..285
FT                   /evidence="ECO:0000250"
FT   CONFLICT        18
FT                   /note="Missing (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        25
FT                   /note="P -> D (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        94..95
FT                   /note="VE -> AG (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        110..111
FT                   /note="TL -> IP (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        130
FT                   /note="K -> R (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147
FT                   /note="L -> V (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        151..152
FT                   /note="PM -> ST (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        156..157
FT                   /note="VV -> LA (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213
FT                   /note="P -> T (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        254..255
FT                   /note="VA -> AG (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        308
FT                   /note="F -> L (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        312
FT                   /note="Q -> P (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320..321
FT                   /note="PT -> AF (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        323
FT                   /note="V -> N (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        384
FT                   /note="S -> R (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        385
FT                   /note="Y -> F (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        388
FT                   /note="A -> T (in Ref. 2; AAC70013)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="T -> A (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          33..35
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          37..40
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          47..55
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           62..64
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          76..80
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          87..89
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           92..102
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          105..107
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          113..115
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          119..124
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          134..140
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   TURN            144..146
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           150..152
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           156..162
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          165..169
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           174..178
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           190..205
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           206..209
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          211..221
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           223..233
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           235..237
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          242..248
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           253..255
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          257..259
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           262..272
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           279..288
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           291..301
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   TURN            302..304
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          308..310
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           312..314
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          325..327
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           332..338
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          346..351
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           358..362
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           374..383
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           385..388
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           392..394
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           395..403
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           409..424
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           426..438
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          443..449
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           469..474
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           477..479
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           486..505
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          524..531
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   STRAND          533..536
FT                   /evidence="ECO:0007744|PDB:5FV4"
FT   HELIX           540..549
FT                   /evidence="ECO:0007744|PDB:5FV4"
SQ   SEQUENCE   566 AA;  62016 MW;  BE046545307DEDE5 CRC64;
     MWLLPLVLTS LASSATWAGQ PASPPVVDTA QGRVLGKYVS LEGLAQPVAV FLGVPFAKPP
     LGSLRFAPPQ PAEPWSFVKN TTSYPPMCCQ DPVVEQMTSD LFTNGKERLT LEFSEDCLYL
     NIYTPADLTK RGRLPVMVWI HGGGLVLGGA PMYDGVVLAA HENVVVVAIQ YRLGIWGFFS
     TGDEHSRGNW GHLDQVAALH WVQENIANFG GDPGSVTIFG ESAGGESVSV LVLSPLAKNL
     FHRAISESGV ALTVALVRKD MKAAAKQIAV LAGCKTTTSA VFVHCLRQKS EDELLDLTLK
     MKFLTLDFHG DQRESHPFLP TVVDGVLLPK MPEEILAEKD FNTVPYIVGI NKQEFGWLLP
     TMMGFPLSEG KLDQKTATSL LWKSYPIANI PEELTPVATD KYLGGTDDPV KKKDLFLDLM
     GDVVFGVPSV TVARQHRDAG APTYMYEFQY RPSFSSDKKP KTVIGDHGDE IFSVFGFPLL
     KGDAPEEEVS LSKTVMKFWA NFARSGNPNG EGLPHWPMYD QEEGYLQIGV NTQAAKRLKG
     EEVAFWNDLL SKEAAKKPPK IKHAEL
//
